Annals of the Rheumatic Diseases, 0003-4967

Journal

1 - 20 out of 158Page size: 20

Publications

  1. 2020
  2. E-pub ahead of print

    Local steroid activation is a critical mediator of the anti-inflammatory actions of therapeutic glucocorticoids

    Adam Croft, Joana Campos, Amy Naylor, Angela Taylor, Myriam Chimen, Gareth Lavery, Karim Raza & Rowan Hardy, 8 Nov 2020, In: Annals of the Rheumatic Diseases.

    Research output: Contribution to journal › Article › peer-review

  3. Published

    Hydroxychloroquine shortages among patients with systemic lupus erythematosus during the COVID-19 pandemic: experience of the Systemic Lupus International Collaborating Clinics

    Caroline Gordon, 25 Jun 2020, In: Annals of the Rheumatic Diseases.

    Research output: Contribution to journal › Letter › peer-review

  4. Published

    SAT0186 Developing predictors of global BILAG treatment response in patients with Lupus Nephritis: more lessons from the Aspreva Lupus Management Study group (ALMS) data

    2 Jun 2020, In: Annals of the Rheumatic Diseases. 79, Suppl 1, p. 1034-1035 2 p.

    Research output: Contribution to journal › Abstract › peer-review

  5. Accepted/In press

    Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis

    Lorraine Harper, Apr 2020, (Accepted/In press) In: Annals of the Rheumatic Diseases.

    Research output: Contribution to journal › Article › peer-review

  6. Published

    Neuropsychiatric events in systemic lupus erythematosus: a longitudinal analysis of outcomes in an international inception cohort using a multistate model approach

    Caroline Gordon & 14 others, , Mar 2020, In: Annals of the Rheumatic Diseases. 79, 3, p. 356-362 7 p.

    Research output: Contribution to journal › Article › peer-review

  7. Accepted/In press

    Disruptive Innovation in Rheumatology; New Networks of Global Public-Private Partnerships are Needed to Take Advantage of Scientific Progress

    Christopher Buckley, 26 Feb 2020, (Accepted/In press) In: Annals of the Rheumatic Diseases. 79, 5

    Research output: Contribution to journal › Article › peer-review

  8. Published

    Open-label randomised pragmatic trial (CONTACT) comparing naproxen and low-dose colchicine for the treatment of gout flares in primary care

    Raymond Oppong, Sue Jowett, Feb 2020, In: Annals of the Rheumatic Diseases. 79, 2, p. 276-284 9 p.

    Research output: Contribution to journal › Article › peer-review

  9. Published

    EULAR recommendations for the management of Sjögren's syndrome with topical and systemic therapies

    Benjamin Fisher & 2 others, Simon Bowman, Jan 2020, In: Annals of the Rheumatic Diseases. 79, 1, p. 3-18 16 p., 216114.

    Research output: Contribution to journal › Article › peer-review

  10. 2019
  11. Published

    Urine metabolic profile in rheumatoid arthritis development

    Stephen Young, 27 Jun 2019, In: Annals of the Rheumatic Diseases. 78, Suppl 2, p. 2129-2130 2 p.

    Research output: Contribution to journal › Abstract › peer-review

  12. Published

    2019 update of the EULAR recommendations for the management of systemic lupus erythematosus

    Caroline Gordon, 29 Mar 2019, In: Annals of the Rheumatic Diseases. 78, 6, p. 736-745 10 p.

    Research output: Contribution to journal › Review article › peer-review

  13. Published

    Current challenges in the development of new treatments for lupus

    Caroline Gordon, 12 Jan 2019, In: Annals of the Rheumatic Diseases. 78, 6, p. 729-735 7 p.

    Research output: Contribution to journal › Article › peer-review

  14. Published

    Phosphatidylinositol 3-kinase delta pathway: a novel therapeutic target for Sjögren's syndrome

    Saba Nayar, Joana Campos, David Gardner, Christopher Buckley, Simon Bowman, Benjamin Fisher & Francesca Barone, 10 Jan 2019, In: Annals of the Rheumatic Diseases. 78, 2, p. 249-260 12 p.

    Research output: Contribution to journal › Article › peer-review

  15. E-pub ahead of print

    Mycophenolate mofetil versus cyclophosphamide for remission induction in ANCA associated vasculitis: a randomised, non-inferiority trial

    Lorraine Harper, 5 Jan 2019, In: Annals of the Rheumatic Diseases.

    Research output: Contribution to journal › Article › peer-review

  16. 2018
  17. Published

    Low aspirin use and high prevalence of preeclampsia risk factors among pregnant women in a multinational SLE inception cohort

    Caroline Gordon, 20 Dec 2018, In: Annals of the Rheumatic Diseases.

    Research output: Contribution to journal › Letter › peer-review

  18. E-pub ahead of print

    Targeting early changes in the synovial microenvironment: a new class of immunomodulatory therapy?

    Jennifer Marshall, Ilfita Sahbudin, Karim Raza, Andrew Filer, Christopher Buckley, 14 Dec 2018, In: Annals of the Rheumatic Diseases.

    Research output: Contribution to journal › Article › peer-review

  19. E-pub ahead of print

    Cardiovascular, thromboembolic and renal outcomes in IgA vasculitis (Henoch-Schönlein purpura): a retrospective cohort study using routinely collected primary care data

    Anuradhaa Subramanian, Nicola Adderley, Lorraine Harper & Krishnarajah Nirantharakumar, 28 Nov 2018, In: Annals of the Rheumatic Diseases.

    Research output: Contribution to journal › Article › peer-review

  20. E-pub ahead of print

    Hexokinase 2 as a novel selective metabolic target for rheumatoid arthritis

    Adam Croft, Christopher Buckley, 30 Jul 2018, In: Annals of the Rheumatic Diseases.

    Research output: Contribution to journal › Article › peer-review

  21. E-pub ahead of print

    Response to: Can ultrasound of the major salivary glands assess histopathological changes induced by treatment with rituximab in primary Sjögren's syndrome?

    Benjamin Fisher & Simon Bowman, 13 Apr 2018, In: Annals of the Rheumatic Diseases.

    Research output: Contribution to journal › Article

  22. Published

    2017 EULAR recommendations for a core data set to support observational research and clinical care in rheumatoid arthritis

    Karim Raza, 12 Mar 2018, In: Annals of the Rheumatic Diseases. 77, p. 476-479

    Research output: Contribution to journal › Article › peer-review

  23. Published

    Effect of rituximab on a salivary gland ultrasound score in primary Sjögren’s syndrome: results of the TRACTISS randomised double-blind multicentre substudy

    Benjamin Fisher & Simon Bowman, 12 Feb 2018, In: Annals of the Rheumatic Diseases. 77, 3, p. 412-416

    Research output: Contribution to journal › Article › peer-review

Previous 1 2 3 4 5 6 7 8 Next